All News

Certain states are proposing that out-of-state telemedicine care should be more accessible, which researchers believe is a trend that will continue.

A new cell isolation kit was approved by the FDA to decrease the amount of time needed in a lab and lower overall costs for testing tuberculosis.

Analyses of more than 30,000 adults in the United Kingdom from 9 prospective cohort studies finds a high pre-pandemic BMI was associated with the infection.

The annual report notes that progress in reducing cancer mortality is uneven among populations, with minority groups not seeing the same benefits from therapeutic advances.

Motivational Interviewing is a collaborative conversation style that can empower patients to stay the course and achieve better outcomes.

Pharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.

Specialty pharmacies need processes, systems and tools to quickly determine medication delivery status, reassure confidence, and alleviate patient anxiety.

Brought to you by The Sassy Pharmacist

Presentation by Chapman University dean highlights patient relations, staffing issues.

Innovative system reveals a pair of potential therapies for autosomal recessive polycystic kidney disease, which currently has no FDA-approved treatments.

The study also showed sustained reductions in hospitalizations over a 2-year period of FreeStyle Libre system use.

Outpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.

In a recent study, researchers observed that more than one-third of children with a primary immunodeficiency disease died from COVID-19.

Research suggests that acupuncture may be able to clinically reduce symptoms of anxiety in this patient population.

Program will start to distribute a free HIV self-test to people who enroll by early 2023.

Danielle Carnival, PhD, addressed the National Comprehensive Cancer Network Policy Summit on Friday.

Semaglutide is a traditional type 2 diabetes treatment that may help obese individuals lose weight, especially if given at a higher dose.

Following the success of the phase 3 EMERGENT-2 trial, researchers suggest that xanomeline-trospium could be a safe and effective treatment option for adults with schizophrenia.

The FDA accepted a supplemental New Drug Application for tucatinib to treat HER2 colorectal cancer, which could significantly improve outcomes for these patients.

The All of Us Research Program looks to enroll more than 1 million US individuals in the next 10 years to enable public access to medical data for research purposes.

The biosimilar matches Prolia in efficacy, immunogenicity, pharmacodynamics, and pharmacokinetics in women who are postmenopausal with osteoporosis.

How would you respond to these patient questions?

Effective use of clinical reasoning might indeed be one of the major driving forces behind practice change toward more patient-centric care.

Pharmacist education also helps prevent adverse reactions, maximizes outcomes for the symptomless disease.

Selpercatinib produced clinically meaningful and durable responses across a variety of tumor types in patients with RET-driven cancers.

After 4 years, the 1-time cost of valoctocogene roxaparvovec appeared to be more cost-effective than the annual cost of emicizumab prophylaxis for hemophilia A, according to a new Draft Evidence Report.

Data showed that Black women, regardless of education level or income, are more likely to reside in disadvantaged neighborhoods, which may contribute to racial disparities in breast cancer.

Eliminating paper prescriptions allows for greater legibility, security, trackability for pharmacists, providers.

Nivolumab is a biomarker that has been shown to benefit the survival of patients with stage 2 melanoma patients compared with placebo.

Janssen’s GUIDE data demonstrate that patients treated with guselkumab less than 2 years after disease onset vs later are more likely to achieve “super-responder” at week 20 through 28.